Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...

The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring vascular health in the brain, improving blood flow and oxygenation. Impaired ...

Dr. Peter Attia has declared war on what he calls the marginal decade, the final years of life that are often plagued by ...

Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

A new study led by the University of Bristol, involving more than one million participants, has found that having lower cholesterol levels may reduce the risk of developing dementia. The study, led by ...

A new breakthrough from researchers at Houston's Rice University could unlock the genetic components that determine several ...